Penn Medicine: University of Pennsylvania Health System — Philadelphia, Pennsylvania

Penn Medicine: University of Pennsylvania Health System is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Penn Medicine: University of Pennsylvania Health System has participated in 12 clinical trials with 9 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Alzheimer Disease.

Sponsors: Eli Lilly and Company, Celgene, Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Penn Medicine: University of Pennsylvania Health System?

Penn Medicine: University of Pennsylvania Health System has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Penn Medicine: University of Pennsylvania Health System conducted?

Penn Medicine: University of Pennsylvania Health System has 12 clinical trials on record, with 9 currently active. Their work covers Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Alzheimer Disease.

Is Penn Medicine: University of Pennsylvania Health System accredited by Crixeo Health?

Yes — Penn Medicine: University of Pennsylvania Health System holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Penn Medicine: University of Pennsylvania Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.